Hyperspectral chemical imaging technologies are frequently applied in the pharmaceutical industry to assess the distribution of ingredients in product intermediates and finished products. This article discusses two recognized measures of spatial uniformity in the context of pharmaceuticals. Synthetic images are used to introduce the utility of Ripley's K-function and the Herfindahl-Hirschman index (HHI) for describing image content. These metrics were applied to a commercial-like product to demonstrate the practical interpretation for product development. The simple approaches presented here offer the possibility of reporting objective measures of intra-tablet compositional uniformity with minimal supervision.
United States Pharmacopeia (USP). <905> Uniformity of Dosage Units. Rockville, MD: United States Pharmacopeial Convention, 2011.
2.
BergumJ.VukovinskyK.E.. “A Proposed Content-Uniformity Test for Large Sample Sizes”. Pharm. Technol.2010. 34(11): 72–79.
3.
ClarkeF.C.JamiesonM.J.ClarkD.A.HammondS.V.JeeR.D.MoffatA.C.. “Chemical Image Fusion. The Synergy of FT-NIR and Raman Mapping Microscopy to Enable a More Complete Visualization of Pharmaceutical Formulations”. Anal. Chem.2001. 73(10): 2213–2220.
4.
BeluA.MahoneyC.WormuthK.. “Chemical Imaging of Drug Eluting Coatings: Combining Surface Analysis and Confocal Raman Microscopy”. J. Control. Release.2008. 126(2): 111–121.
5.
SasicS.ClarkD.A.. “Defining a Strategy for Chemical Imaging of Industrial Pharmaceutical Samples on Raman Line-Mapping and Global Illumination Instruments”. Appl. Spectrosc.2006. 60(5): 494–502.
6.
ZhangL.HensonM.J.SekulicS.S.. “Multivariate Data Analysis for Raman Imaging of a Model Pharmaceutical Tablet”. Anal. Chim. Acta.2005. 545(2): 262–278.
7.
GendrinC.RoggoY.ColletC.. “Pharmaceutical Applications of Vibrational Chemical Imaging and Chemometrics: A Review”. J. Pharm. Biomed. Anal.2008. 48(3): 533–553.
8.
SacréP.Y.De BleyeC.ChavezP.-F.NetchacovitchL.HubertP.ZiemonsE.. “Data Processing of Vibrational Chemical Imaging for Pharmaceutical Applications”. J. Pharm. Biomed. Anal.2014. 101: 123–140.
9.
DepkinC.A.II. “Free Agency and the Concentration of Player Talent in Major League Baseball”. J. Sports Econ.2002. 3(4): 335–353.
HirschmanA.O.. “On Measures of Dispersion for a Finite Distribution”. J. Am. Stat. Assoc.1943. 38(223): 346–352.
13.
AyalaG.EpifanioI.SimóA.ZapaterV.. “Clustering of Spatial Point Patterns”. Comput. Stat. Data Anal.2006. 50(4): 1016–1032.
14.
MarconE.PuechF.. “Evaluating the Geographic Concentration of Industries Using Distance-Based Methods”. J. Econ. Geogr.2003. 3(4): 409–428.
15.
TriasD.GarciaR.CostaJ.BlancoN.HurtadoJ.E.. “Quality Control of CFRP by Means of Digital Image Processing and Statistical Point Pattern Analysis”. Compos. Sci. Technol.2007. 67(11-12): 2438–2446.
16.
RipleyB.D.. “The Second-Order Analysis of Stationary Point Processes”. J. Appl. Probab.1976. 13(2): 255–266.
International Conference on Harmonization of Technical Requirements of Registration of Pharmaceuticals for Human Use (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R1). Geneva, Switzerland: ICH, 2005.
19.
JovanovićN.GerichA.BouchardA.JiskootW.. “Near-Infrared Imaging for Studying Homogeneity of Protein-Sugar Mixtures”. Pharm. Res.2006. 23(9): 2002–2013.
20.
WestenbergerB.J.EllisonC.D.FussnerA.S.JenneyS.KolinskiR.E.LipeT.G.LyonR.C.MooreT.W.RevelleL.K.SmithA.P.SpencerJ.A.StoryK.D.TolerD.Y.WokovichA.M.BuhseL.F.. “Quality Assessment of Internet Pharmaceutical Products Using Traditional and Non-Traditional Analytical Techniques”. Int. J. Pharm.2005. 306(1-2): 56–70.
21.
PuchertT.LochmannD.MenezesJ.C.ReichG.. “Near-Infrared Chemical Imaging (NIR-CI) for Counterfeit Drug Identification—a Four-Stage Concept with a Novel Approach of Data Processing (Linear Image Signature)”. J. Pharm. Biomed. Anal.2010. 51(1): 138–145.
22.
HamadM.L.EllisonC.D.KhanM.A.LyonR.C.. “Drug Product Characterization by Macropixel Analysis of Chemical Images”. J. Pharm. Sci.2007. 96(12): 3390–3400.
23.
RosasJ.G.BlancoM.. “A Criterion for Assessing Homogeneity Distribution in Hyperspectral Images. Part 1: Homogeneity Index Bases and Blending Processes”. J. Pharm. Biomed. Anal.2012. 70: 680–690.
24.
RosasJ.G.BlancoM.. “A Criterion for Assessing Homogeneity Distribution in Hyperspectral Images. Part 2: Application of Homogeneity Indices to Solid Pharmaceutical Dosage Forms”. J. Pharm. Biomed. Anal.2012. 70: 691–699.
25.
DevoreJ.L.. Probability and Statistics for Engineering and the Sciences. Pacific Grove, CA: Duxbury, 2000. 5th ed.
26.
HuaM.AndersonC.A.. “Characterization of Pharmaceutical Powder Blends by NIR Chemical Imaging”. J. Pharm. Sci.2008. 97(8): 3305–3320.
27.
KucheryavskiS.. “Extracting Useful Information from Images”. Chemom. Intell. Lab. Syst.2011. 108(1): 2–12.
28.
HildenL.R.PommierC.J.BadawyS.I.F.FriedmanE.M.. “NIR Chemical Imaging to Guide/Support BMS-561389 Tablet Formulation Development”. Int. J. Pharm.2007. 353(1-2): 283–290.
29.
ReedM.G.HowardC.V.. “Edge-Corrected Estimators of the Nearest Neighbor Distance Function for Three-Dimensional Point Patterns”. J. Microsc.1997. 186(2): 177–184.
